BoomerangFX launches ChatGPT search advertising for private clinics
BoomerangFX is launching an AI search marketing offering for aesthetic, wellness and private healthcare practices, combining eligible paid search advertising on ChatGPT with search optimization for Claude and Gemini. The service will initially roll out in the United States, Canada and the United Kingdom through the company’s GROW Platinum upgrade.
- BoomerangFX is launching AI search marketing for private healthcare, wellness and aesthetic practices.
- The service combines eligible ChatGPT advertising with optimization for Claude and Gemini.
- AUVIA supports multilingual chat, lead qualification, booking, payments and follow-up.
- The launch begins in the US, Canada and UK in November 2026.
- Expansion is planned for Ireland, Germany, Australia, India and Latin America.
One platform for AI discovery and patient conversion
BoomerangFX said the offering connects AI search advertising on OpenAI’s ChatGPT with organic search optimization for Claude and Gemini. It is designed to link patient inquiries with lead generation, conversion, clinic operations and payments in a single software platform.
The company describes the service as the world’s first specialized AI search marketing platform to combine ChatGPT advertising campaigns, optimization for Claude and Gemini, and agentic patient interactions. Those interactions include integrated electronic medical records, appointment management and payments.
BoomerangFX said the offering is available to existing and new customers through its GROW Platinum upgrade. The company also said it uses conventional platforms including Google, Meta and Instagram to extend campaign reach.
AUVIA handles responses, qualification and follow-up
The GROW suite’s Smart Website Intelligence organizes treatment expertise, clinician qualifications, practice locations and patient education into web content intended to be accessible to AI platforms. BoomerangFX said its search optimization technology helps those platforms discover, interpret and reference the information when prospective patients search for care.
Paid ChatGPT search advertising is combined with website and content optimization for discovery through Claude and Gemini. Visitors can use the resulting experiences to learn about services, interact with the practice and book appointments, according to the company.
AUVIA™, described by BoomerangFX as a specialized, multi-LLM AI clinical copilot, automates immediate responses and personalized follow-up. Its functions include multilingual chat, lead qualification, appointment coordination, payment workflows, reminders and follow-up. Campaign and conversion signals are used for ongoing optimization, linking marketing activity with patient engagement and appointments made.
BoomerangFX said its team has completed more than 10,000 Google, Meta and Instagram campaigns over the past ten years. The company also said AUVIA’s specialized knowledge framework covers more than 2,000 treatment and clinical indication entries, while clinical assessment and treatment selection remain the practitioner’s responsibility.
RUN, GROW and ELEVATE connect the clinic workflow
The new channel is connected to three BoomerangFX solutions. RUN provides practice management and electronic medical records, including appointments, digital records, consents, treatment records, electronic prescribing, inventory and reporting. The system also links these functions with billing, payments and patient financing.
GROW covers lead acquisition, pipeline management, Smart Website Intelligence and conversion workflows. ELEVATE provides specialized marketing strategy and execution, including positioning, website optimization, campaign development, paid media and ongoing optimization.
Together, the systems are intended to manage the relationship from an initial inquiry through patient interactions and into RUN for treatment documentation, compliance, payments and continuing care. BoomerangFX said the coordinated model is designed to improve conversion, reduce missed inquiries and increase patient lifetime value.
Initial rollout starts in November 2026
BoomerangFX said the offering will launch in November 2026 in the United States, Canada and the United Kingdom. The company plans to expand into Ireland, Germany, Australia, India and Latin America.
The announcement positions AI assistants as an increasingly important starting point for people researching aesthetic and wellness treatments. BoomerangFX cited an August 2026 Pew Research Center report saying that 34% of US adults now use AI chatbots for at least one health or medical reason.
For clinics, the launch combines visibility across AI search services with automated patient communication and existing operational tools. The company’s chief executive, Jerome Dwight, said the aim is to connect demand generated through marketing with the experience clinics provide.
